Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8.Global Topical Drug Delivery Market, by Product
8.1 Semi-Solid Formulations
8.2 Liquid Formulations
8.3 Solid Formulations
8.4 Transdermal Products
9.Global Topical Drug Delivery Market, by Route of Administration
9.1 Dermal Drug Delivery
9.2 Ophthalmic Drug Delivery
9.3 Rectal Drug Delivery
9.4 Vaginal Drug Delivery
9.5 Nasal Drug Delivery
10.Global Topical Drug Delivery Market, by Facility of Use
10.1 Home Care Settings
10.2 Hospitals & Clinics
10.3 Burn Centers
10.4 Other Facilities
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12.Company Profiles
12.1 LLC, IDEMIA
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 L3Harris Technologies Inc.
12.3 Rapiscan Systems
12.4 Smiths Detection Inc.
12.5 Teledyne e2v
12.6 3DX-RAY
12.7 Astrophysics Inc.
12.8 Autoclear
12.9 Leidos
12.10 Nuctech Company Limited
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
